Drug Addiction Treatment Act (DATA)

The Drug Addiction Treatment Act (DATA) allows qualified healthcare providers to prescribe certain medications for opioid addiction treatment in office settings, rather than only in specialized clinics. Specifically, it permits the use of buprenorphine, a medication that reduces withdrawal symptoms and cravings. To do this, providers must meet specific training and certification requirements and obtain a waiver from the DEA. This law aims to improve access to effective addiction treatment, making it easier for individuals to get help through their regular healthcare providers, thus integrating addiction care into general medical practice.